Tag Archives: Erenumab

If you follow the science sections of the general media, you may have seen reports of a new migraine drug called Erenumab. The drug is not yet on the market but shows promise having just come through the final phases of clinical testing. Erenumab, made by Novartis, is one of several similar drugs being developedContinue reading “New migraine drug hails the future of therapeutic development”